Dice therapeutics 10q
WebNov 9, 2024 · Dice Therapeutics, Inc. (DICE) SEC Filing 10-Q Quarterly Report for the period ending Friday, September 30, 2024 WebMar 15, 2024 · Inside Dice Therapeutics, Inc.'s 10-K Annual Report: Financial - Income Highlight. The increase of $5.1 million was primarily due to interest income earned on …
Dice therapeutics 10q
Did you know?
WebApr 6, 2024 · DICE Therapeutics, Inc. (DICE) - DEFA14A - Additional Proxy Soliciting Materials (definitive) SEC Filings Tue, Apr. 26, 2024 DICE Therapeutics, Inc. (DICE) - … WebMar 30, 2024 · Posted by ABMN Staff on Mar 30th, 2024. DICE Therapeutics, Inc. ( NASDAQ:DICE – Get Rating) Director Ra Capital Management, L.P. purchased 155,089 shares of the company’s stock in a transaction that occurred on Thursday, March 23rd. The shares were purchased at an average cost of $26.67 per share, with a total value of …
WebWe design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. We are developing a growing pipeline of high-impact oral therapeutic candidates. Our lead program targets the IL-17 cytokine for psoriasis and other IL-17 mediated diseases. WebApr 6, 2024 · finance.yahoo.com - March 23 at 8:25 PM. Here’s Why Meridian Small Cap Growth Fund Trimmed DICE Therapeutics (DICE) finance.yahoo.com - March 22 at 8:21 AM. DICE Therapeutics (NASDAQ:DICE) Shares Down 6.8%. americanbankingnews.com - March 22 at 6:44 AM. Insider Selling: DICE Therapeutics, Inc. (NASDAQ:DICE) Director …
WebApr 10, 2024 · DICE Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights Mar 01, 2024. DICE Therapeutics Announces Late … WebOct 13, 2024 · Find the latest SEC Filings data for DICE Therapeutics, Inc. Common Stock (DICE) at Nasdaq.com.
WebJan 24, 2024 · Financials. According to the 10-Q SEC Filing, DICE Therapeutics had cash, cash equivalents and marketable securities of $266.6 million as of September 30, 2024. This was an okay amount of cash ...
WebApr 1, 2024 · DICE Therapeutics Stock Performance. Shares of DICE opened at $28.67 on Friday. DICE Therapeutics has a 52-week low of $12.64 and a 52-week high of $45.99. The firm has a market cap of $1.37 billion, a price-to-earnings ratio of -13.40 and a beta of 0.71. The business's fifty day moving average is $29.47 and its 200-day moving average is … cities skylines nightWebDICE Therapeutics Inc. SEC filings breakout by MarketWatch. View the DICE U.S. Securities and Exchange Commission reporting information. diary of a wimpy kid tv show castWebApr 10, 2024 · According to 15 analysts, the average rating for DICE stock is "Buy." The 12-month stock price forecast is $63.97, which is an increase of 138.43% from the latest price. diary of a wimpy kid tv show disney plusWebDec 31, 2024 · You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on … cities skylines next releaseWebSep 30, 2024 · FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the … diary of a wimpy kid tubiWebNov 9, 2024 · The Investor Relations website contains information about DICE Therapeutics's business for stockholders, potential investors, and financial analysts. cities skylines not enough fuelWebOct 25, 2024 · DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. ... (SEC) pursuant to Rule 424(b)(4) on September 16, 2024, and our other SEC filings. Accordingly, readers are ... diary of a wimpy kid twisted wizard